Human epididymis protein 4—a promising biomarker—has been commonly used in many malignant tumors, especially in ovarian cancer.[11,35,36] The sensitivity and specificity of HE4 was higher than that of cancer antigen 125 as a tumor marker for ovarian cancer diagnosis. Here, MUC16 is linked to neoplasm.